ADUS SEC Filing News — Addus HomeCare Corporation

Latest SEC filings for Addus HomeCare Corporation (ADUS) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-09-14.

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care,…
Sector: Healthcare Industry: Medical Care Facilities Market Cap: $2.2B CIK: 1468328
20
Total Filings
0
Bullish Classifications
5
Bearish Classifications
12
Insider Transactions
5
Material Events (8-K)
3
Periodic Reports
Rule-based classifications for ADUS currently lean bearish. Of the 20 filing records displayed, 5 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
ADUS Filing Activity Snapshot 2026-03-03 — 2026-09-14
Insider Transactions (Form 4)
0 buys vs 5 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$27.0K
Dixon Heather Brianne (President and Chief Operating) · 2026-06-23
288 shares · Form 4
Insider Transactions 12 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 12 filings in this group are Form 4s for Addus HomeCare Corporation.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 12 insider filings shown, the breakdown is 7 compensation award and 5 open-market sale. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Compensation award ×7
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Open-market sale ×5
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Form 4 Open-market sale Insider Selling 2026-06-23

ADUS insider Dixon Heather Brianne (President and Chief Operating) sold 288 shares (~$27.0K)

Dixon Heather Brianne, listed as President and Chief Operating at Addus HomeCare Corp, reported an open-market sale of 288 ADUS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 288 $93.77 $27.0K
Filing: Form 4 (Insider Transaction) Insider: Dixon Heather Brianne (President and Chief Operating) Shares: 288 Est. Value: $27.0K
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

Hill-Milbourne Veronica (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: Hill-Milbourne Veronica (Director) Shares: 1,449
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

Lopez Esteban (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: Lopez Esteban (Director) Shares: 1,449
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

RUSH JEAN (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: RUSH JEAN (Director) Shares: 1,449
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

Weaver Susan T (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: Weaver Susan T (Director) Shares: 1,449
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

Gordon Darin J. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: Gordon Darin J. (Director) Shares: 1,449
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

FIRST MARK L (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: FIRST MARK L (Director) Shares: 1,449
Form 4 Compensation award Tax / Compensation Filing 2026-06-11

ADUS insider Form 4 filed for equity award, exercise, or tax withholding

EARLEY MICHAEL (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 1,449 — —
Filing: Form 4 (Insider Transaction) Insider: EARLEY MICHAEL (Director) Shares: 1,449
Form 4 Open-market sale Insider Selling 2026-05-22

ADUS insider Lopez Esteban (Director) sold 250 shares (~$23.2K)

Lopez Esteban, listed as Director at Addus HomeCare Corp, reported an open-market sale of 250 ADUS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 250 $93.00 $23.2K
Filing: Form 4 (Insider Transaction) Insider: Lopez Esteban (Director) Shares: 250 Est. Value: $23.2K
Form 4 Open-market sale Insider Selling 2026-05-21

ADUS insider Lopez Esteban (Director) sold 250 shares (~$23.2K)

Lopez Esteban, listed as Director at Addus HomeCare Corp, reported an open-market sale of 250 ADUS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 250 $93.00 $23.2K
Filing: Form 4 (Insider Transaction) Insider: Lopez Esteban (Director) Shares: 250 Est. Value: $23.2K
Form 4 Open-market sale Insider Selling 2026-04-22

ADUS insider BLESSING CLIFF DONALD (EVP, Chief Development Officer) sold 178 shares (~$16.7K)

BLESSING CLIFF DONALD, listed as EVP, Chief Development Officer at Addus HomeCare Corp, reported an open-market sale of 178 ADUS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 178 $93.61 $16.7K
Filing: Form 4 (Insider Transaction) Insider: BLESSING CLIFF DONALD (EVP, Chief Development Officer) Shares: 178 Est. Value: $16.7K
Form 4 Open-market sale Insider Selling 2026-03-03

ADUS insider RAINES MONICA (EVP, CCO and Quality Officer) sold 224 shares (~$22.9K)

RAINES MONICA, listed as EVP, CCO and Quality Officer at Addus HomeCare Corp, reported an open-market sale of 224 ADUS shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 224 $102.15 $22.9K
Filing: Form 4 (Insider Transaction) Insider: RAINES MONICA (EVP, CCO and Quality Officer) Shares: 224 Est. Value: $22.9K
Material Events 5 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 5 in this period for Addus HomeCare Corporation. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-09-14

ADUS filed 8-K — material company event

Addus HomeCare Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-13

ADUS filed 8-K — material company event

Addus HomeCare Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-08-03

ADUS filed 8-K — material company event

Addus HomeCare Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-06-10

ADUS filed 8-K — material company event

Addus HomeCare Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Form 8-K Material Company Update 2026-05-04

ADUS filed 8-K — material company event

Addus HomeCare Corp filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)
Periodic Reports 3 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 1 annual report (10-K) and 2 quarterly reports (10-Q) for Addus HomeCare Corporation.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-08-04

ADUS filed Quarterly Report (10-Q)

Addus HomeCare Corp filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
Form 10-Q Quarterly Report 2026-05-05

ADUS filed Quarterly Report (10-Q)

Addus HomeCare Corp filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)
Form 10-K/A Annual Report Amendment 2026-03-12

ADUS filed amended Annual Report (10-K/A)

Addus HomeCare Corp filed its amended annual report with the SEC. This amendment updates or corrects a previously filed annual report.

Filing: 10-K/A (Annual Report Amendment)

How we classify Addus HomeCare Corporation's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on ADUS. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — ADUS SEC Filings

More Tools for ADUS

Want deeper ADUS analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the ADUS stock analysis page.

ADUS Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer